跳至主要内容
临床试验/NCT02061852
NCT02061852终止不适用

Prospective Trial for the Evaluation of Safety, Tolerability and Efficacy of the Medical Device Simeox ® Compared to Traditional Respiratory Physiotherapy Techniques for Airway Secretion Clearance

Physio-Assist2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2014年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Physio-Assist
入组人数
15
试验地点
2
主要终点
Safety of the simeox®

研究概览

简要总结

The purpose of this study is to determine whether the medical device "simeox" is safe in the treatment of respiratory diseases, in comparison with traditional physiotherapy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient over 18, male or female.
  • Patient affected by broncho-degenerative disease, chronic obstructive airway disease, cystic fibrosis, idiopathic bronchiectasis, ciliary dyskinesia and/or chronic bronchitis.
  • Hospitalization for a minimum of five days or a maximum of 8 days.
  • Bronchial clearance is usually productive.
  • FVC and / or FEV <85% predicted, with stable lung function.
  • Agreement to participate to the study and signature of the informed consent form
  • Social security coverage.

排除标准

  • Patient infected with bacteria resistant to antibiotics.
  • Bronchial clearance is not usually productive.
  • Patient with contra-indication for physiotherapy bronchial clearance.
  • Patient who received a lung transplant.
  • Care requires more than 2 sessions of chest physiotherapy daily.
  • Duration of mechanical ventilation > 8h/day.
  • Patient with an episode of hemoptysis during the month before inclusion.
  • Patient with an episode of pneumothorax during the last month.
  • Pregnant or lactating women.
  • Patient with a disability and/or unwillingness to follow protocol requirements.
  • Patient participating in another clinical study or having tested an experimental drug within 30 days prior to his inclusion in the study.
  • Patient ( s) with another condition which, according to the investigator , may interfere with the result or conduct of the trial and thus justify their non- inclusion in the study.

研究组 & 干预措施

Physiotherapy

Active Comparator

Traditional techniques

干预措施: Physiotherapy (Procedure)

Physiotherapy

Active Comparator

Traditional techniques

干预措施: Simeox (Device)

simeox

Experimental

Medical device

干预措施: Simeox (Device)

simeox

Experimental

Medical device

干预措施: Physiotherapy (Procedure)

结局指标

主要结局

Safety of the simeox®

时间窗: Day 8

Adverse events related or not to the simeox®

次要结局

未报告次要终点

研究者

发起方
Physio-Assist
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验